«Short-term efficacy of a monoclonal antibody fragment (brolucizumab) for treating neovascular age-related macular degeneration». Ukrainian Journal of Ophthalmology , вип. 3, Липень 2024, с. 28-32, https://doi.org/10.31288/oftalmolzh202432832.